Welcome to our dedicated page for Dlh Holdings news (Ticker: DLHC), a resource for investors and traders seeking the latest updates and insights on Dlh Holdings stock.
DLH Holdings Corp. (NASDAQ: DLHC) is a leading provider of technology-enabled business process outsourcing and program management solutions in the United States. The company leverages digital transformation, artificial intelligence, analytics, cloud-based applications, and telehealth systems to support large-scale federal health and human services initiatives. DLH's mission is to be the most trusted provider of technology-enabled healthcare and public health services, medical logistics, and readiness enhancement services to those securing the freedom of our nation, veterans, and underserved communities.
DLH delivers professional healthcare and public services to several government agencies, including the U.S. Departments of Defense, Health and Human Services, and Veterans Affairs. The company is engaged in key areas such as defense and veterans health solutions, human services and solutions, and public health and life sciences. With more than 3,200 employees working across 30 states, DLH brings a unique combination of government sector experience and commitment to innovation.
DLH has been recognized by GovWin IQ as a top service provider in the health services spending category. Recently, the company has seen significant growth and further debt reduction, positioning it well for future endeavors. The company continually strives to enhance technology, public health, and cybersecurity readiness through science, technology, cyber, and engineering solutions and services.
One notable achievement is DLH's new award with the National Institute on Drug Abuse (NIDA), valued at approximately $23 million. This contract includes managing the operations of an integrated advanced clinical/research informatics system, supporting the research, design, development, and maintenance of clinical and scientific informatics, and providing IT infrastructure and desktop support. This partnership underscores DLH’s commitment to delivering superb execution and excellence in public health services.
Financially, DLH has reported a positive trajectory with increased income from operations, higher net income, and a robust backlog of projects. For the first quarter of fiscal 2024, the company recorded income from operations of $6.8 million, and net income of approximately $2.2 million, showing significant improvement compared to the previous year. As of the latest updates, the total backlog stands at approximately $736.2 million, signaling strong future performance and continued growth.
DLH Holdings Corp. (NASDAQ: DLHC) has secured an Indefinite Delivery/Indefinite Quantity (ID/IQ) contract with the Department of Veteran Affairs (VA) aimed at enhancing healthcare innovations. This contract, part of the Accelerating VA Innovation and Learning (AVAIL) initiative, features a five-year base period with a ceiling of $650 million across 17 competitors. DLH will utilize its expertise in digital health tools and advanced technologies to support Veterans with improved care solutions.
DLH Holdings Corp. (NASDAQ: DLHC) reported fiscal Q3 2022 results with revenue of $66.4 million, an 8% increase year-over-year. Earnings rose to $4.9 million, or $0.34 per diluted share, up from $2.9 million or $0.21 per diluted share in Q3 2021. The operating margin improved to 10.7% from 8.0%. Debt was reduced to $28.5 million, down from $37.5 million. Contract backlog stood at $509.7 million as of June 30, 2022. The company secured two major contracts with federal agencies, enhancing its growth prospects for fiscal 2023.
DLH Holdings Corp. (NASDAQ: DLHC) is set to release its fiscal third-quarter financial results on August 2, 2022. The results will cover the period ended June 30, 2022. Following the financial release, a conference call is scheduled for August 3, 2022, at 10:00 a.m. ET, where senior management will discuss the results and operational trends. Interested parties can participate via phone or access the presentation materials on the Investor Relations section of the DLH website. A digital recording of the call will be available afterward.
DLH Holdings Corp. (NASDAQ: DLHC) announced that its subsidiary, Social & Scientific Systems, Inc., secured an Indefinite Delivery/Indefinite Quantity (ID/IQ) contract with the National Cancer Institute (NCI). This contract allows DLH to support cancer research in various task areas including study management and biospecimen activities, with a potential ceiling of $320 million over ten years. The contract replaces previous NCI agreements and positions DLH to enhance its public health missions, particularly in cancer prevention and research.
DLH Holdings Corp. (NASDAQ: DLHC) announced a new contract with the National Institute of Environmental Health Sciences (NIEHS) to provide statistical, mathematical, and computational support. This award, valued at approximately $13 million, spans one year with four additional one-year options. DLH will deliver software programming, research support, and data visualization focusing on areas like carcinogenesis and toxicology. The contract continuation highlights DLH's strong partnership with NIEHS, showcasing its expertise in public health and scientific research.
DLH Holdings Corp. (NASDAQ: DLHC) announced an award of an Indefinite Delivery/Indefinite Quantity (ID/IQ) contract with the Department of Defense. This contract involves health-related research and support services, focusing on medical simulation, infectious diseases, and battlefield healthcare. It has a potential total ceiling of $10 billion over five years, with task orders to be competed as needed. The initiative aligns with DLH's expertise in digital transformation and medical research, positioning the company to enhance military health readiness.
DLH Holdings Corp. (NASDAQ: DLHC) reported a strong fiscal second quarter for 2022, achieving revenue of $108.7 million, a significant increase from $61.5 million in Q2 2021. This growth was primarily driven by two FEMA contracts worth approximately $39.8 million. Earnings were $7.2 million or $0.50 per share, up from $2.6 million or $0.19 per share year-over-year. The company reduced term debt to $37.5 million and reported a backlog of $554.7 million. Management remains optimistic about future opportunities and ongoing debt repayment.
DLH Holdings Corp. (NASDAQ: DLHC) announced on April 21, 2022, the awarding of a new contract to provide ongoing support to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This contract has a total value of approximately $14 million and includes a base period of one year with four optional extensions. DLH will assist in epidemiological research, statistical programming, and data analysis related to chronic diseases. The company emphasizes its commitment to improving public health through its partnership with NIDDK.
DLH Holdings Corp. (NASDAQ: DLHC) will announce its fiscal second quarter financial results for the period ending March 31, 2022, on May 4, 2022, after market close. Following this, a conference call is scheduled for May 5, 2022, at 11:00 a.m. ET, where senior management will discuss the financial results and operational trends, followed by a Q&A session. Interested parties can listen in by calling 888-347-5290 or 412-317-5256. More details and presentation materials will be available on the Investor Relations section of DLH's website.
FAQ
What is the current stock price of Dlh Holdings (DLHC)?
What is the market cap of Dlh Holdings (DLHC)?
What services does DLH Holdings Corp. provide?
Which government agencies does DLH serve?
How many employees does DLH have?
What are the key areas of DLH's services?
Has DLH received any recent recognitions?
What are some of DLH's recent financial achievements?
What recent contract has DLH secured with NIDA?
What technologies does DLH leverage in its operations?
What is DLH's mission?
Where can I find more information about DLH?
